NCT04635527 A Study on the Safety and Effectiveness of IBI318 Combined With Conventional TACE (cTACE) as a Perioperative Treatment for Potentially Resected Hepatocellular Carcinoma Status TERMINATED Phase PHASE1
NCT04631731 Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity Status RECRUITING Phase PHASE1/PHASE2
NCT04627363 HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama Status UNKNOWN Phase PHASE2
NCT04627012 Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma Status COMPLETED Phase N/A
NCT04620538 Volatile Organic Compounds for the Assessment of Liver Disease Status COMPLETED Phase N/A
NCT04601961 Effects of TIVA Versus Inhalational Anaesthesia on Circulating Tumour Cells in Hepatocellular Carcinoma Patients Status UNKNOWN Phase NA
NCT04597970 TACE Plus HAIC With Oxaliplatin and Raltitrexed for BCLC Stage C HCC Status UNKNOWN Phase PHASE2
NCT04595864 Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation Status RECRUITING Phase PHASE3
NCT04587739 Neoadjuvant Hypofractionated Stereotactic Body Radiation Therapy Prior to Surgery for Hepatocellular Carcinoma: a Feasibility Study. Status RECRUITING Phase PHASE1
NCT04580485 INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04576572 Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma Status COMPLETED Phase N/A
NCT04573881 The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK) Status ACTIVE_NOT_RECRUITING Phase NA
NCT04572633 The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy Status ACTIVE_NOT_RECRUITING Phase NA
NCT04569799 Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE Status COMPLETED Phase PHASE4
NCT04567615 A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors Status COMPLETED Phase PHASE2